Bowel (colorectal) cancer - UK mortality statistics
This page presents mortality statistics for bowel cancer by country in the UK and age. There are also data on trends over time, geographic variation and socioeconomic group. The ICD-10 codes for bowel cancer are C18-C21 (which include the colon, rectum, rectosigmoid junction and anus).
Bowel cancer is the third most common cause of cancer death among men in the UK, accounting for 11% of all male deaths from cancer. It is the third most common cause of death among women, responsible for 10% of all female cancer deaths.
In 2009, there were 15,908 deaths from bowel cancer in the UK (Table 2.1): 8,600 (54%) in men and 7,308 (46%) in women, giving a male:female ratio of 12:10.1-3 These comprised 9,831 (62%) deaths from colon cancer and 6,077 (38%) deaths from rectal cancer (including the anus). Most rectal cancer deaths are in men (3,524 or 58% male) but colon cancer deaths are approximately evenly divided between men and women (5,076 or 52% male). The crude mortality rate shows that there were around 28 bowel cancer deaths for every 100,000 males in the UK and 23 for every 100,000 females.
European age-standardised rates (ASRs) of bowel cancer deaths are significantly lower in England compared with the Scotland, Wales (males only) and Northern Ireland (females only).1-3 Rates do not differ significantly between Wales, Scotland and Northern Ireland.
A north-south divide in bowel cancer mortality rates has existed across the UK since at least the 1990s;12 the most recent data for England shows that rates are still higher in the north for males, but a clear divide is much less evident for females.4
Table 2.1: Bowel Cancer (C18-C21), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2009
| Colorectal (C18-C21) | England | Scotland | Wales | Northern Ireland | UK | |
| Male | Deaths | 6,978 | 836 | 564 | 222 | 8,600 |
| Crude Rate | 27.3 | 33.2 | 38.5 | 25.3 | 28.3 | |
| AS Rate | 20.7 | 25.3 | 26.0 | 22.8 | 21.4 | |
| AS Rate - 95% LCL* | 20.2 | 23.6 | 23.9 | 19.8 | 20.9 | |
| AS Rate - 95% UCL* | 21.1 | 27.1 | 28.2 | 25.8 | 21.8 | |
| Female | Deaths | 5,944 | 742 | 414 | 208 | 7,308 |
| Crude Rate | 22.6 | 27.7 | 27.0 | 22.8 | 23.3 | |
| AS Rate | 13.0 | 16.2 | 14.3 | 15.5 | 13.4 | |
| AS Rate - 95% LCL* | 12.7 | 15.0 | 12.9 | 13.4 | 13.1 | |
| AS Rate - 95% UCL* | 13.3 | 17.3 | 15.7 | 17.6 | 13.7 | |
| Persons | Deaths | 12,922 | 1,578 | 978 | 430 | 15,908 |
| Crude Rate | 24.9 | 30.4 | 32.6 | 24.0 | 25.7 | |
| AS Rate | 16.4 | 20.1 | 19.4 | 18.7 | 17.0 | |
| AS Rate - 95% LCL* | 16.1 | 19.1 | 18.2 | 16.9 | 16.7 | |
| AS Rate - 95% UCL* | 16.7 | 21.1 | 20.6 | 20.4 | 17.2 | |
| Colon (C18) | England | Scotland | Wales | Northern Ireland | UK | |
| Male | Deaths | 4,180 | 416 | 352 | 128 | 5,076 |
| Crude Rate | 16.4 | 16.5 | 24.0 | 14.6 | 16.7 | |
| AS Rate | 12.2 | 12.5 | 15.9 | 13.2 | 12.4 | |
| AS Rate - 95% LCL* | 11.8 | 11.3 | 14.3 | 10.9 | 12.1 | |
| AS Rate - 95% UCL* | 12.6 | 13.7 | 17.6 | 15.4 | 12.8 | |
| Female | Deaths | 3,915 | 430 | 271 | 139 | 4,755 |
| Crude Rate | 14.9 | 16.1 | 17.7 | 15.3 | 15.1 | |
| AS Rate | 8.4 | 9.1 | 9.0 | 10.2 | 8.5 | |
| AS Rate - 95% LCL* | 8.1 | 8.2 | 8.0 | 8.5 | 8.3 | |
| AS Rate - 95% UCL* | 8.6 | 9.9 | 10.1 | 11.9 | 8.8 | |
| Persons | Deaths | 8,095 | 846 | 623 | 267 | 9,831 |
| Crude Rate | 15.6 | 16.3 | 20.8 | 14.9 | 15.9 | |
| AS Rate | 10.1 | 10.6 | 12.0 | 11.6 | 10.3 | |
| AS Rate - 95% LCL* | 9.8 | 9.8 | 11.1 | 10.2 | 10.1 | |
| AS Rate - 95% UCL* | 10.3 | 11.3 | 13.0 | 13.0 | 10.5 | |
| Rectum (C19-C21) | England | Scotland | Wales | Northern Ireland | UK | |
| Male | Deaths | 2,798 | 420 | 212 | 94 | 3,524 |
| Crude Rate | 11.0 | 16.7 | 14.5 | 10.7 | 11.6 | |
| AS Rate | 8.5 | 12.9 | 10.1 | 9.7 | 8.9 | |
| AS Rate - 95% LCL* | 8.2 | 11.6 | 8.7 | 7.7 | 8.7 | |
| AS Rate - 95% UCL* | 8.8 | 14.1 | 11.4 | 11.6 | 9.2 | |
| Female | Deaths | 2,029 | 312 | 143 | 69 | 2,553 |
| Crude Rate | 7.7 | 11.6 | 9.3 | 7.6 | 8.1 | |
| AS Rate | 4.6 | 7.1 | 5.2 | 5.3 | 4.9 | |
| AS Rate - 95% LCL* | 4.4 | 6.3 | 4.4 | 4.0 | 4.7 | |
| AS Rate - 95% UCL* | 4.8 | 7.9 | 6.1 | 6.5 | 5.1 | |
| Persons | Deaths | 4,827 | 732 | 355 | 163 | 6,077 |
| Crude Rate | 9.3 | 14.1 | 11.8 | 9.1 | 9.8 | |
| AS Rate | 6.4 | 9.6 | 7.4 | 7.1 | 6.7 | |
| AS Rate - 95% LCL* | 6.2 | 8.9 | 6.6 | 6.0 | 6.5 | |
| AS Rate - 95% UCL* | 6.5 | 10.3 | 8.2 | 8.2 | 6. | |
*95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS rate
section updated 27/01/12
Bowel cancer mortality is strongly related to age. In the UK between 2007 and 2009, an average 80% of bowel cancer deaths were in people aged 65 years and over (Figure 2.1).1-3 Mortality rates increase sharply from around age 50 in men and around age 65 in women, reaching a peak at age 85+ in both sexes. The male:female ratio increases with age, from 12:10 at age 50-54, to 14:10 at age 85+.
Figure 2.1: Bowel Cancer (C18-C21) Average Number of Deaths Per Year and Age-Specific Mortality Rates, UK, 2007-2009
19% of bowel cancer deaths occur in people aged 60-69. People in England and Northern Ireland are currently offered bowel screening at two-year intervals between ages 60 and 69. In Scotland people are offered screening from ages 50 to 74. In Wales people are offered screening from ages 60 to 74. In England screening is gradually being extended to include people aged 70-74.
section updated 27/01/12
Bowel cancer mortality rates have overall decreased in the UK since the early 1970s (Figure 2.2).1-3 For men, European age-standardised mortality rates were 35% lower in 2007-09 than in 1971-73. For women, rates were 47% lower in 2007-09 than in 1971-73.
For both sexes, UK bowel cancer mortality rates decreased steadily from the early 1970s to the early 1990s, and have decreased more rapidly since then. In the early 1970s around 33 males per 100,000 died from bowel cancer each year; by the early 1990s this had fallen to around 30 per 100,000; and by the late 2000s it had further fallen to around 22 per 100,000. For females, the bowel cancer mortality rate fell from 26 per 100,000 in the early 1970s; to around 20 per 100,000 in the early 1990s; and to around 14 per 100,000 in the late 2000s. There are probably a combination of reasons for the decline in bowel cancer mortality rates, including earlier detection and better treatment.
Bowel screening has been shown to reduce the risk of dying from bowel cancer by a quarter in people who are screened in England.13A similar risk reduction has recently been observed in an, as yet, unpublished study in Scotland.14,15
Figure 2.2: Bowel Cancer (C18-C21), European Age-Standardised Mortality Rates, UK, 1971-2009
UK bowel cancer mortality rates have decreased for all age groups in the last 40 years (Figure 2.3), with larger drops in younger age groups.1-3 Between 1971-73 and 2007-09, bowel cancer mortality rates fell by 48% in people aged 45-59, 40% in 60-69 year-olds, 39% in 70-79 year-olds, and 33% in people aged 80+. The lower mortality decreases in the older age groups may be explained in part by the under-staging and under-treatment of the elderly.5 The impact of screening on mortality rates in different age groups should be seen in the data in the coming years.
Figure 2.3: Bowel Cancer (C18-21), European Age-Standardised Mortality Rates, Persons, By Age, UK, 1971-2009
section updated 27/01/12
Bowel cancer is the fourth most common cause of cancer death worldwide, estimated to be responsible for almost 610,000 deaths in 2008 (around 8% of the total). Bowel cancer mortality rates are lowest in Middle Africa and South-Central Asia and highest in Central and Eastern Europe, with a six-fold variation in male mortality rates between the regions of the world, and a five-fold variation in female rates (Figure 2.4).6
Figure 2.4: Bowel cancer (C18-C21), World Age-Standardised Mortality Rates, World Regions, 2008 Estimates
Within the 27 countries of the European Union (EU-27), the highest bowel cancer mortality rates are in Hungary for both sexes (48.1 male deaths per 100,000, 25.0 deaths per 100,000); and the lowest rates are in Cyprus (11.4 male deaths per 100,000, 8.0 female deaths per 100,000) (Figure 2.5).7
Figure 2.5: Bowel cancer (C18-C21), European Age-Standardised Mortality Rates, EU-27 Countries, 2008 Estimates
UK bowel cancer mortality rates are 23rd (males) and joint 20th (females) highest in Europe (EU-27).
section updated 27/01/12
Male bowel cancer mortality rates are around 20% higher in the most deprived wards of England and Wales as compared with the least deprived wards,8 reflecting higher incidence in these groups.11 There is no obvious association with deprivation for females in England and Wales,8 or for either sex in Scotland and Northern Ireland.9,10
section updated 27/01/12

Visit our A-Z topic pages
References for bowel cancer mortality
- Office for National Statistics Mortality Statistics: Deaths registered in 2009, England and Wales (PDF 798KB) 2010, National Statistics:London
- General Register Office for Scotland 2010 Deaths Time Series Data, Deaths in Scotland in 2009
- Northern Ireland Statistics and Research Agency Registrar General Annual Report 2010
- National Cancer Intelligence Network, UK. Cancer e-atlas. Accessed December 2011
- Papamichael D, et al. Treatment of the elderly colorectal cancer patient: SIOG expert recommendations. Ann Oncol, 2009. 20(1): p.5-16
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2. Cancer Incidence and Mortality Worldwide: IARC Cancerbase No.10 [Internet] Lyon, France: International Agency for Research on Cancer; 2010. Available from http://globocan.iarc.fr
- European Age-Standardised rates calculated by the Statistical Information Team at Cancer Research UK, 2011 using data from GLOBOCAN 2008 v1.2, IARC, version 1.2. http://globocan.iarc.fr
- Romeri E, Baker A and Griffiths C. Mortality by deprivation and cause of death in England and Wales, 1999-2003 (523KB) National Statistics., Health Statistics Quarterly Winter 2006.
- Scottish Public Health Observatory, UK Colorectal cancer (ICD-10 C18-C20). Scotland: age-standardised incidence and mortality rates (EASRs), by SIMD 2006 deprivation quintile. Accessed December 2011.
- Northern Ireland Cancer Registry, UK. Cancer in Northern Ireland 1993-2001: A Comprehensive Report 23. Chapter 5: Cancer of the Colon (C18). Accessed December 2011.
- National Cancer Intelligence Network (NCIN) Cancer incidence by Deprivation December 2008.
- Quinn M WH, Cooper N, Rowan S. Cancer Atlas of the United Kingdom and Ireland 1991-2000 (PDF 423KB) Office for National Statistics: 2005
- Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007;(1):CD001216.
- Libby G, Brewster D, Fraser C, Carey F, Steele R. The impact of population-based faecal occult blood screening on colorectal cancer mortality: A matched cohort study. Abstract from the 7th NCRI Cancer Conference, Liverpool, 6-9 November 2011
- Wise J. Population based screening in Scotland reduces bowel cancer deaths BMJ. 2011 Nov 9;343:d7304.


